PBIO (Pressure BioSciences) NonCurrent Deferred Liabilities: $0.01 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PBIO Pressure BioSciences Inc PBIO
12 GF Score
Price $0.00
View Full Analysis

What is Pressure BioSciences NonCurrent Deferred Liabilities?

Pressure BioSciences PBIO 12 NonCurrent Deferred Liabilities is $0.01 Mil as of Jun. 2024. GuruFocus rates PBIO with a GF Score™ of 12/100.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Pressure BioSciences's non-current deferred liabilities for the quarter that ended in Jun. 2024 was $0.01 Mil.

Pressure BioSciences NonCurrent Deferred Liabilities Related Terms

Pressure BioSciences NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Pressure BioSciences's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pressure BioSciences NonCurrent Deferred Liabilities Chart

Pressure BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.02 0.00 0.00 0.01

Pressure BioSciences Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01
PBIO
12GF Score
Pressure BioSciences Inc PBIO
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $0.01 Mil mean?
Pressure BioSciences (PBIO) has a NonCurrent Deferred Liabilities of $0.01 Mil as of Jun. 2024. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Pressure BioSciences and its competitors.
Is Pressure BioSciences' NonCurrent Deferred Liabilities too high?
Pressure BioSciences' current NonCurrent Deferred Liabilities is $0.01 Mil. Overall, Pressure BioSciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Pressure BioSciences' NonCurrent Deferred Liabilities compare to EMED and CUTRQ?
Pressure BioSciences' NonCurrent Deferred Liabilities of $0.01 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Pressure BioSciences and its competitors. Pressure BioSciences's current NonCurrent Deferred Liabilities is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pressure BioSciences stock overvalued right now?
Pressure BioSciences (PBIO) has a current NonCurrent Deferred Liabilities of $0.01 Mil. The current NonCurrent Deferred Liabilities is $0.01 Mil. Pressure BioSciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Pressure BioSciences (PBIO), the current NonCurrent Deferred Liabilities is $0.01 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pressure BioSciences Business Description

Address 14 Norfolk Avenue, South Easton, MA, USA, 02375
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
12GF Score

Get the complete analysis for PBIO

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price